Metabolic targeting of platelets to combat thrombosis: dawn of a new paradigm?
{{output}}
Current antithrombotic therapies used in clinical settings target either the coagulation pathways or platelet activation receptors (P2Y12 or GPIIb/IIIa), as well as the cyclooxygenase (COX) enzyme through aspirin. However, they are associated with bleeding ris... ...
